Institute For Hepatitis is categorized under Medical Research in Doylestown, PA and active since 2002.
Institute For Hepatitis was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 8139100 by the NAICS.
If you are seeking more information, feel free to contact Nelson Carvalho, Marketing at the company’s single location by writing to 3805 Old Easton Road, Doylestown, Pennsylvania PA 18902 or by phoning (215) 589-6361. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Institute For Hepatitis |
| Contact Person: | Nelson Carvalho, Marketing |
| Address: | 3805 Old Easton Road, Doylestown, Pennsylvania 18902 |
| Phone Number: | (215) 589-6361 |
| Website Address: | hepb.org |
| Annual Revenue (USD): | Unknown |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 8139100 |
| Share This Business: |
Institute For Hepatitis was started in 2002 to provide professional Medical Research under the SIC code 8733 and NAICS code 8139100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Nelson Carvalho, Marketing for inquiries that concern Institute For Hepatitis by calling the company number (215) 589-6361, as your correspondence is most welcome. Additionally, the physical location of the single location of Institute For Hepatitis can be found at the coordinates 40.33258,-75.12647 as well as the street address 3805 Old Easton Road in Doylestown, Pennsylvania 18902.
For its online presence, you may visit Institute For Hepatitis’s website at hepb.org and engage with its social media outlets through on Twitter and on Facebook.